MSB 0.93% $1.09 mesoblast limited

Ann: FDA Supports Accelerated Approval Pathway for Heart Failure, page-428

  1. 7,768 Posts.
    lightbulb Created with Sketch. 1337
    If that's the line of thinking, we know that the independent parties who HAVE seen the data have turned MSB down multiple times - the FDA and Novartis.

    A look under the hood was all it took for Novartis. Wonder why?

    And the FDA can support pathways for accelerated approval all day. The real money is actually getting approval, so we can chat about that when it happens hey?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.09
Change
0.010(0.93%)
Mkt cap ! $1.244B
Open High Low Value Volume
$1.07 $1.10 $1.05 $4.880M 4.545M

Buyers (Bids)

No. Vol. Price($)
2 54894 $1.09
 

Sellers (Offers)

Price($) Vol. No.
$1.10 24700 1
View Market Depth
Last trade - 16.10pm 17/06/2024 (20 minute delay) ?
Last
$1.09
  Change
0.010 ( 0.40 %)
Open High Low Volume
$1.07 $1.10 $1.05 1011230
Last updated 15.59pm 17/06/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.